Compare LITS & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITS | PLSM |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | Israel |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 38.5M |
| IPO Year | N/A | N/A |
| Metric | LITS | PLSM |
|---|---|---|
| Price | $1.15 | $3.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 231.4K | 2.9K |
| Earning Date | 05-12-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $3.00 |
| 52 Week High | $3.03 | $6.85 |
| Indicator | LITS | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 40.40 |
| Support Level | $1.17 | $3.00 |
| Resistance Level | $1.26 | $3.93 |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 54.05 | 39.78 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.